LABCORP HOLDINGS INC. Stock Issued During Period, Shares, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LABCORP HOLDINGS INC. stock issued during period, shares, acquisitions for the quarter ending 2015-12-31 was 0.00 shares.
- LABCORP HOLDINGS INC. stock issued during period, shares, acquisitions for the quarter ending 2015-09-30 was 0.00 shares.
- LABCORP HOLDINGS INC. stock issued during period, shares, acquisitions for the quarter ending 2015-06-30 was 0.00 shares.
- LABCORP HOLDINGS INC. stock issued during period, shares, acquisitions for the quarter ending 2015-03-31 was 15.30M shares.
- LABCORP HOLDINGS INC. stock issued during period, shares, acquisitions for fiscal 2017 was 15.30M shares, a 0.00% change from fiscal 2016.
- LABCORP HOLDINGS INC. stock issued during period, shares, acquisitions for fiscal 2016 was 15.30M shares, a 0.00% change from fiscal 2015.
- LABCORP HOLDINGS INC. stock issued during period, shares, acquisitions for fiscal 2015 was 15.30M shares.
| Period end | Stock Issued During Period, Shares, Acquisitions 3 month | Stock Issued During Period, Shares, Acquisitions 12 month |
|---|---|---|
| 2017-12-31 | 15.30M shares 10-K · filed 2018-02-27 | |
| 2016-12-31 | 15.30M shares 10-K · filed 2017-02-27 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | 15.30M shares 10-K · filed 2016-03-01 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | |
| 2015-03-31 | 15.30M shares 10-Q · filed 2015-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |